Market Research Logo

Drug Testing: Technologies and Global Markets

Drug Testing: Technologies and Global Markets

The global drug of abuse (DOA) testing market reached nearly $2.8 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach almost $3.5 billion by 2019.

This report provides:

An overview of the global market for drug testing technologies.

Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.

An overview of drug abuse trends in terms of various geographic regions as well as drug classes.

Information on leading players in the market and their key products.

Analysis of leading companies in the field and their successful strategies.


This report contains:

An overview of drug abuse trends in terms of various geographic regions as well as drug classes.

Drug abuse statistics in key regions.

Analysis of regulatory environments in North, South and Central America, Europe, and Asia-Pacific, and country-wise summaries of national legislation and policies.

Drug of abuse testing markets with respect to testing approaches and sample matrices.

Technology trends in the drug of abuse testing market.

Leading players in the market and their key products.

Sales projections through 2019 for drug of abuse testing markets by sample matrix and geographic regions.

Analysis of leading companies and their successful strategies.

CHAPTER 1 INTRODUCTION
STUDY GOAL AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY
INFORMATION SOURCES
ANALYST’S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL DRUGS OF ABUSE TESTING MARKET FORECAST BY TEST MATRIX, THROUGH 2019 ($ MILLIONS)
SUMMARY FIGURE GLOBAL DRUGS OF ABUSE TESTING MARKET FORECAST BY REGION, 2013-2019 ($ MILLIONS)
CHAPTER 3 DRUGS OF ABUSE TESTING PRACTICES
SINGLE- VS MULTI-PARAMETER TEST
DOA SCREENING
CONFIRMATION TESTING
URINE TESTS
OTHER TESTING METHODS
BLOOD TESTING
ORAL FLUID TESTING
SALIVA TESTING
SWEAT TESTING
HAIR TESTING
TESTING LOCATIONS
LABORATORY-BASED DAT
Criminal Justice
Police
Prisons
Probation
Workplace Screening
Others
Military
Customs and Excise
Education
POINT OF CARE (POC) DATS
TABLE 1 ADVANTAGES AND DISADVANTAGES OF POINT OF CARE
TESTING
ONSITE TESTING VS LABORATORY TESTING
TABLE 2 MAJOR ADVANTAGES AND DISADVANTAGES OF ONSITE TESTING
SAMPLE TYPES FOR LABORATORY TESTING
URINE TESTING
HAIR TESTING
SALIVA/ORAL FLUID TESTING
BLOOD TESTING
SWEAT TESTING
EYE REFLEX
DETECTION PERIOD
TABLE 3 DETECTION PERIODS FOR VARIOUS TYPES OF DRUG TESTING
FOOLING A DRUG TEST
FOOLING URINE TESTING
TABLE 4 COMMON PARAMETERS TESTED FOR URINE SPECIMEN VALIDITY
TABLE 5 SOME OF THE COMMERCIAL/COMMON ADULTERANTS USED IN FOOLING URINE TESTS AND THEIR EFFECTS
FOOLING HAIR TESTING
FOOLING SALIVA TESTING
SAMPLE VALIDITY TESTS
TABLE 6 URINE SAMPLE VALIDITY TEST METHODS
FALSE POSITIVES AND FALSE NEGATIVES
FALSE POSITIVES
TABLE 7 CROSS REACTANTS THAT CAN LEAD TO FALSE POSITIVES IN DOA TESTING
FALSE NEGATIVES
TESTING TECHNOLOGIES
IMMUNOASSAYS
ENZYME IMMUNOASSAY (EIA)
ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
ENZYME MULTIPLIED IMMUNOASSAY TECHNOLOGY (EMIT)
FLUORESCENCE POLARIZATION IMMUNOASSAY (FPIA)
RADIOIMMUNOASSAY (RIA)
CHROMATOGRAPHY
Gas Chromatography (GC)
High Performance Liquid Chromatography (HPLC)
Thin-Layer Chromatography (TLC)
Mass Spectrometry (MS)
Capillary Electrophoresis (CE)
Hyphenated MS/Chromatography
Gas-Chromatography-Mass Spectrometry (GC/MS)
EYE REFLEX MEASUREMENTS
CHAPTER 4 GOVERNMENT REGULATIONS: DRUG TRAFFICKING AND DRUG ABUSE TESTING
NORTH AMERICA
NATIONAL LEGISLATION AND POLICY
Canada
Drug Free Workplace
Mexico
The United States
Drug-Free Workplace
TABLE 8 U.S. DRUG TESTING LEGISLATIONS BY STATE, 2014
U.S. Department of Transportation
Drug Testing in the Military
Public Assistance Qualifications
Drug Testing for Individuals Convicted of Drug Felonies
2014 Legislation
Legislative Proposals:
Legislative Enactments:
Quick Facts
2013 Legislation
Legislative Proposals:
Legislative Enactments:
2012 Legislation
Programs Included
2011 Legislation
SOUTH AMERICA
NATIONAL LEGISLATION AND POLICY
Bolivia
Brazil
Drug-Free Workplace
Colombia
Ecuador
Guyana
Paraguay
Peru
CENTRAL AMERICA AND THE CARIBBEAN
NATIONAL LEGISLATION AND POLICY
Costa Rica
Cuba
El Salvador
Guatemala
Haiti
Jamaica
Nicaragua
Panama
Tegucigalpa
The Bahamas
The Netherlands Antilles
Trinidad and Tobago
EUROPE
NATIONAL LEGISLATION AND POLICY
Bosnia and Herzegovina
Denmark
France
Germany
Italy
Latvia
Norway
Romania
Sweden
Switzerland
The Netherlands
The United Kingdom
DRUG-FREE WORKPLACE POLICY AND LEGISLATION BY EUROPEAN
COUNTRY
TABLE 9 DRUG-TESTING LEGISLATION BY EUROPEAN COUNTRY, 2008*
ASIA-PACIFIC
NATIONAL LEGISLATION AND POLICY
Australia
Bangladesh
Bhutan
Cambodia
Hong Kong
India
The NDPS (Regulation of Controlled Substances) Order, 1993
Japan
Maldives
Myanmar
Nepal
New Zealand
Singapore
South Korea
Sri Lanka
Taiwan
Thailand
Vietnam
CHAPTER 5 OVERVIEW
DRUG ABUSE TESTING
INTRODUCTION
INTERNATIONAL DRUG TRAFFICKING AND ILLICIT DRUG USE TRENDS BY DRUG TYPE
TABLE 10 NUMBER OF ILLICIT DRUG USERS GLOBALLY, 2003-2007 (MILLIONS)
Amphetamine-Type Stimulants Market
Cannabis Market
Coca/Cocaine Market
Opium/Heroin Market
INTERNATIONAL DRUG TRAFFICKING AND ILLICIT DRUG USE TRENDS BY GEOGRAPHIC REGION
Africa
Central America and Caribbean
North America
TABLE 11 NORTH AMERICAN DOA SEIZURES, 2012
South America
East and Southeast Asia
South Asia
West Asia
Europe
TABLE 12 ANNUAL PREVALENCE OF OPIOID USE AS A PERCENTAGE OF THE POPULATION AGED 15-64 BY MOST RECENT DATA YEAR
TABLE 13 ANNUAL PREVALENCE OF COCAINE USE AS A PERCENTAGE OF THE POPULATION AGED 15-64 BY MOST RECENT DATA YEAR
TABLE 14 ANNUAL PREVALENCE OF CANNABIS USE AS A PERCENTAGE OF THE POPULATION AGED 15-64 BY MOST RECENT DATA YEAR
TABLE 15 ANNUAL PREVALENCE OF ATS USE AS A PERCENTAGE OF THE POPULATION AGED 15-64 BY MOST RECENT DATA YEAR
TABLE 16 ANNUAL PREVALENCE OF ECSTASY USE AS A PERCENTAGE OF THE POPULATION AGED 15-64 BY MOST RECENT DATA YEAR
Oceania
U.S. DRUGS OF ABUSE STATISTICS
National Household Survey on Drug Abuse: SAMHSA U.S.
Survey by Drug Type
TABLE 17 DRUG ABUSE STATISTICS IN THE U.S. BY DRUG TYPE (12 YRS AND OLDER), 2011 AND 2012 (THOUSANDS)
Survey by Age
TABLE 18 ILLICIT DRUG USE IN LIFETIME AMONG PERSONS 12 YRS AND OLDER IN THE U.S. BY AGE, 2011 AND 2012 (THOUSANDS)
TABLE 19 ILLICIT DRUG USE IN LIFETIME AMONG PERSONS 12 YRS AND OLDER IN THE U.S. BY GENDER, RACE, AND ETHNICITY, 2011 AND 2012 (THOUSANDS)
Survey by Education and Current Employment Status
TABLE 20 ILLICIT DRUG USE IN LIFETIME AMONG PERSONS AGED
12 OR OLDER BY GENDER, RACE, EDUCATION AND EMPLOYMENT, 2011 AND 2012 (THOUSANDS)
CHAPTER 6 GLOBAL DRUGS OF ABUSE TESTING MARKET BY SAMPLE
MATRIX
DRUGS OF ABUSE TESTING SALES
TABLE 21 GLOBAL SALES CONTRIBUTION FOR DRUGS OF ABUSE TESTING BY SAMPLE MATRIX, THROUGH 2019 (%)
TABLE 22 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY SAMPLE MATRIX, THROUGH 2019 ($ MILLIONS)
FIGURE 1 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY SAMPLE MATRIX, 2013-2019 ($ MILLIONS)
GLOBAL SALES OF DRUGS OF ABUSE TESTING BY URINE
TABLE 23 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY URINE, THROUGH 2019 ($ MILLIONS)
FIGURE 2 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY URINE, 2013-2019 ($ MILLIONS)
TABLE 24 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY URINE: LABORATORY BASED VERSUS ONSITE, THROUGH 2019 ($ MILLIONS)
FIGURE 3 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY URINE: LABORATORY BASED VERSUS ONSITE, 2014 (%)
GLOBAL SALES OF DRUGS OF ABUSE TESTING BY BLOOD
TABLE 25 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY BLOOD, THROUGH 2019 ($ MILLIONS)
FIGURE 4 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY BLOOD, 2013-2019 ($ MILLIONS)
GLOBAL SALES OF DRUGS OF ABUSE TESTING BY ORAL FLUID
TABLE 26 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY ORAL FLUID, THROUGH 2019 ($ MILLIONS)
FIGURE 5 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY ORAL FLUID, 2013-2019 ($ MILLIONS)
TABLE 27 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY ORAL FLUID: LABORATORY BASED VERSUS ONSITE, THROUGH 2019 ($ MILLIONS)
FIGURE 6 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY ORAL: LABORATORY BASED VERSUS ONSITE, 2014 (%)
GLOBAL SALES OF DRUGS OF ABUSE TESTING BY HAIR
TABLE 28 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY HAIR, THROUGH 2019 ($ MILLIONS)
FIGURE 7 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY HAIR, 2013-2019 ($ MILLIONS)
GLOBAL SALES OF DRUGS OF ABUSE TESTING BY SWEAT
TABLE 29 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY SWEAT, THROUGH 2019 ($ MILLIONS)
FIGURE 8 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY SWEAT, 2013-2019 ($ MILLIONS)
GLOBAL SALES OF DRUGS OF ABUSE TESTING BY OTHER SAMPLE MATRICES
TABLE 30 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY OTHER SAMPLE MATRICES, THROUGH 2019 ($ MILLIONS)
FIGURE 9 GLOBAL SALES FORECAST FOR DRUGS OF ABUSE TESTING BY OTHER SAMPLE MATRICES, 2013-2019 ($ MILLIONS)
CHAPTER 7 WORLDWIDE INDUSTRY STRUCTURE
REGIONAL ANALYSIS
FIGURE 10 DRUGS OF ABUSE TESTING MARKETS BY GEOGRAPHIC REGION, 2014 (%)
TOTAL DOA TESTING AND DRUG MONITORING MARKETS AND FORECASTS
TABLE 31 GLOBAL DRUGS OF ABUSE TESTING MARKET FORECAST BY REGION, THROUGH 2019 ($ MILLIONS)
GROWTH TRENDS-LABORATORY-BASED AND ONSITE DOA TESTING MARKETS
LABORATORY-BASED DOA TESTING MARKETS AND FORECASTS
TABLE 32 DRUGS OF ABUSE TESTING MARKET FORECAST FOR LABORATORY-BASED TESTING, THROUGH 2019 ($ MILLIONS)
ONSITE DOA TESTING MARKETS AND FORECASTS
TABLE 33 DRUGS OF ABUSE TESTING MARKET FORCAST FOR ONSITE
TESTING, THROUGH 2019 ($ MILLIONS)
COMPETITIVE ANALYSIS
TABLE 34 MOST NOTABLE MERGERS AND ACQUISITIONS IN THE DOA TESTING MARKETS, 2000-2012
KEY MARKET PLAYERS IN THE DOA TESTING MARKETS AND THEIR PRODUCTS
TABLE 35 MAJOR COMPANIES AND THEIR PRODUCTS IN THE DOA
TESTING MARKET
LABORATORY-BASED DOA TESTING MARKET SEGMENT
TABLE 36 COMPANIES OFFERING LABORATORY-BASED DOA TESTING
PRODUCTS
ONSITE TESTING MARKET SEGMENT FOR DOA
TABLE 37 MAIN ONSITE DOA TESTING MARKET PLAYERS AND THEIR
PRODUCTS
COMMON DRUGS OF ABUSE AND MOST POPULAR DEVICES USED FOR TESTING THEM
TABLE 38 COMMON DOA AND POPULAR URINE DRUG SCREENING
PRODUCTS
COMPANIES IN THE ORAL FLUID, HAIR, AND SWEAT TESTING SEGMENTS FOR DOA
TABLE 39 KEY MARKET PLAYERS OFFERING DOA TESTING PRODUCTS
ON ORAL FLUID, HAIR AND SWEAT SAMPLE MATRICES
CHAPTER 8 PATENT ANALYSIS
TABLE 40 U.S. DRUGS OF ABUSE TESTING PATENTS BY PATENT NUMBER AND TITLE, 2007-2014
TABLE 41 U.S. DRUGS OF ABUSE TESTING PATENTS BY ASSIGNEE, 978-2007
CHAPTER 9 COMPANY PROFILES
ABBOTT LABORATORIES
ACON LABORATORIES INC.
AGILENT TECHNOLOGIES
ALERE INC.
AMERICAN BIO MEDICA CORP. (ABMC)
BECKMAN COULTER
BIO-RAD LABORATORIES, INC
CONCATENO, PLC
ELITECH GROUP
F. HOFFMANN-LA ROCHE LTD.
MEDTOX DIAGNOSTICS
MICROGENICS
NANOGEN INC.
OLYMPUS DIAGNOSTICS SYSTEMS
ORASURE TECHNOLOGIES INC.
ORTHO-CLINICAL DIAGNOSTICS
SIEMENS HEALTHCARE DIAGNOSTICS INC.
CHAPTER 10 APPENDIX A
TABLE 42 GLOSSARY OF COMMON TERMS
TABLE 43 GLOSSARY OF SCIENTIFIC ABBREVIATIONS
TABLE 44 ASSOCIATIONS
CHAPTER 11 APPENDIX B
TABLE 45 DOA SEIZURES IN EUROPE, 2012

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report